臨牀消化器内科 Vol.34 No.11(4-1)


特集名 胃癌診療2019―現状と課題
題名 胃癌治療の現状と課題 (1) 胃癌治療ガイドライン第5版を巡って
発刊年月 2019年 10月
著者 佐野 武 がん研有明病院
【 要旨 】 「胃癌治療ガイドライン」は2001年に初版が出版され,わが国初の悪性腫瘍治療ガイドラインとして,多様化する胃癌治療法の選択に重要なインパクトを与えた.当時はRCTに基づくエビデンスがほとんど存在せず,「胃癌治療ガイドライン」は教科書スタイルで記述されたが,その後ガイドラインが示す標準治療を対照とする臨床試験が次々と行われ,新しいエビデンスが創出されて改訂を重ねるにつれ,EBMスタイルが取り入れられつつある.2018年1月の第5版では,外科,内視鏡ともに新知見が盛り込まれ,クリニカル・クエスチョンが充実したが,とくに化学療法分野では「推奨レジメン」と「条件付き推奨レジメン」のカテゴリー分けが行われ,多様な病態への対応が可能となった.
Theme Clinical Diagnosis and Management of Gastric Cancer 2019 -- Current Status and Issues
Title Evolution of Gastric Cancer Treatment Guidelines
Author Takeshi Sano Department of Gastroenterology, Fukuoka University Chikushi Hospital
[ Summary ] The first edition of Japanese gastric cancer treatment guidelines was published in 2001 as the first cancer guideline in Japan and had an important impact on treatment decisions that were previously made without scientific evidence. Since then, clinical trials have been conducted using the guideline recommendations and these have produced new evidence. The guidelines were first written in a Textbook style and have been transformed to the Evidence Based Medicine style based on rapidly emerging significant evidence, especially in the chemotherapy field. In the latest 5th edition, each section of surgery, endoscopy and chemotherapy includes new recommendations and clinical questions. Chemotherapy regimens for advanced disease are now categorized into "Recommended regimens" and "Conditionally recommended regimens", which provides a wide range of treatment choice for various patient conditions.
戻る